Literature DB >> 28265643

Subconjunctival Bevacizumab Injection Impairs Corneal Innervations and Epithelial Wound Healing in Mice.

Muchen Dong1, Guohu Di2, Xiaoping Zhang3, Qingjun Zhou2, Weiyun Shi2.   

Abstract

Purpose: To investigate the effects of subconjunctival bevacizumab injection on the corneal nerve, sensitivity, and epithelial wound healing in mice.
Methods: Adult C57BL/6 mice were treated with subconjunctival injection of 1, 2, 5, or 25 mg/mL bevacizumab. The corneal nerve was observed with whole-mount anti-β3-tubulin fluorescence staining. Corneal sensitivity was measured with a Cochet-Bonnet esthesiometer. The protein levels of pigment epithelium-derived factor (PEDF), nerve growth factor (NGF), glial-derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF) were measured by ELISA. The corneal epithelial wound-healing rate was evaluated by fluorescein staining. The recovery of impaired mouse corneal innervations and epithelial wound-healing rate following bevacizumab injection was evaluated with the co-injection of PEDF, NGF, or CNTF.
Results: Subconjunctival bevacizumab injection caused apparent corneal nerve degeneration, attenuated corneal sensitivity, and delayed corneal epithelial wound healing and nerve regeneration in normal mice, which was more significant with increased concentration and times of the bevacizumab injection. However, the corneal nerve and sensitivity gradually improved and recovered in mice with a single injection of 1 to 5 mg/mL bevacizumab. Moreover, the bevacizumab injection significantly decreased the corneal PEDF, NGF, and CNTF content, whereas exogenous PEDF, NGF, or CNTF supplement attenuated impairment of the corneal nerve, sensitivity, and epithelial wound healing after subconjunctival bevacizumab injection. Conclusions: Subconjunctival bevacizumab injection impairs corneal innervations, epithelial wound healing, and nerve regeneration in normal mice, which may be caused by the reduction of neurotrophic factor content in the cornea.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28265643     DOI: 10.1167/iovs.16-20926

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Complications of intrastromal bevacizumab injection in lamellar keratoplasty.

Authors:  Mohammad Soleimani; Ahad Shahbazi; Nader Mohammadi; Seyed Ali Tabatabaei
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

2.  Netrin-1 promotes diabetic corneal wound healing through molecular mechanisms mediated via the adenosine 2B receptor.

Authors:  Yangyang Zhang; Peng Chen; Guohu Di; Xia Qi; Qingjun Zhou; Hua Gao
Journal:  Sci Rep       Date:  2018-04-16       Impact factor: 4.379

3.  Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization.

Authors:  Hyeon Jeong Yoon; Je Moon Woo; Yong Sok Ji; Kyung Chul Yoon
Journal:  Medicina (Kaunas)       Date:  2019-11-07       Impact factor: 2.430

4.  DNase I improves corneal epithelial and nerve regeneration in diabetic mice.

Authors:  Jing Zhang; Yunhai Dai; Chao Wei; Xiaowen Zhao; Qingjun Zhou; Lixin Xie
Journal:  J Cell Mol Med       Date:  2020-03-13       Impact factor: 5.310

5.  The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration.

Authors:  Luqin Wan; Xiaofei Bai; Qingjun Zhou; Chen Chen; Huifeng Wang; Ting Liu; Junfa Xue; Chao Wei; Lixin Xie
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

6.  Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice.

Authors:  Zhenzhen Zhang; Xiaoli Hu; Xia Qi; Guohu Di; Yangyang Zhang; Qian Wang; Qingjun Zhou
Journal:  Mol Vis       Date:  2018-04-01       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.